new molecules and indications for glp 1 medicines GLP1 now address weight loss other health conditions through innovative formulations and expanded indications, highlighting key questions about their efficacy and safety. https://t.co/mFXshd3YYp GLP-1 2.0: Where the Next

Here's what you can do about it.

Berberine has been studied

See the full study design, ingredients breakdown, and results.

I'm pleased to share that npj Metabolic Health and Disease is joining Communications Medicine on a new collection looking at the Therapeutic Landscape of GLP1 agonists.

/PRNewswire/ -- Amble Health, a healthcare platform built to close the wealth gap in metabolic care, today announced the launch of the Amble Cares Program

Background Idiopathic intracranial hypertension (IIH) is a debilitating neurologic condition marked by elevated intracranial pressure (ICP), typically affecting obese women of reproductive age